Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Attenuated live vaccine used for preventing toxoplasma infection and application of attenuated live vaccine

A technology of live attenuated vaccines and Toxoplasma gondii, which is applied in anti-infective drugs, protozoan antigen components, drug combinations, etc., can solve the problem of limitation, achieve huge application value, strong immune protection, and prevent normal infection

Inactive Publication Date: 2017-11-03
LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the only live attenuated Toxoplasma gondii vaccine that can be marketed in the world is S48, but it is limited to the application of local goats and sheep

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Attenuated live vaccine used for preventing toxoplasma infection and application of attenuated live vaccine
  • Attenuated live vaccine used for preventing toxoplasma infection and application of attenuated live vaccine
  • Attenuated live vaccine used for preventing toxoplasma infection and application of attenuated live vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0018] The present invention will be further described below with reference to the accompanying drawings. It should be noted that the following examples are based on the technical solution, and provide detailed implementations and specific operation processes, but the scope of the present invention is not limited to this implementation. example.

[0019] 1. Preparation of live attenuated vaccines

[0020] Inoculate HFF cells into a 25T cell culture flask, add 8 ml of 10% FBS in DMEM medium, and at 37 °C CO 2 Cultivated in an incubator. After the cells are completely confluent, change to 8ml of DMEM medium with 2% FBS and add 100ul of RHΔGRA17 strains at 37°C CO. 2 Culture in an incubator until Toxoplasma gondii escapes from the cells, collect the RHΔGRA17 tachyzoites that have just escaped from the HFF, pass the cell suspension through a 3 μm filter to remove cell debris, and then adjust the concentration of tachyzoites to 500 with sterile PBS / 200μL.

[0021] The immunizat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an attenuated live vaccine used for preventing toxoplasma infection and application of the attenuated live vaccine. The attenuated live vaccine takes PBS as a solvent to prepare a tachyzoite suspension of a toxoplasmosis attenuative strain RHdetltaGRA17. An immune preparation for the attenuated live vaccine is established, the immunization procedure and the inoculum size of the vaccine are explored, and the animal experiment shows that the attenuated live vaccine has a stronger immunoprotection function for the acute infection, the chronic infection and the congenital infection of toxoplasmosis, the normal infection of the toxoplasmosis is prevented, meanwhile, the mother-to-fetus vertical propagation of the toxoplasmosis is effectively stopped, and the vaccine has a huge application value, and can be used for preventing the acute infection, the chronic infection and the congenital infection of toxoplasmosis.

Description

technical field [0001] The invention relates to the field of live attenuated vaccines of Toxoplasma gondii, in particular to a live attenuated vaccine for preventing Toxoplasma gondii infection and its application. Background technique [0002] Toxoplasmosis is a zoonotic parasitic disease caused by Toxoplasma gondii. About one-third of the world's population is infected. Infection of Toxoplasma gondii during pregnancy, Toxoplasma gondii can be transmitted vertically to the fetus through the placenta and then cause pregnancy miscarriage, premature birth, fetal malformation, stillbirth and hinder the normal growth of young children, which seriously endangers the reproductive health of human beings. Toxoplasma gondii can infect almost all warm-blooded animals, is highly infectious, has a wide range of epidemics, and has a wide host spectrum. The disease can still be controlled with drugs in the acute phase, but once it turns to the chronic phase, there is currently no cure. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/002A61P33/02
CPCA61K39/002
Inventor 王金磊黄思扬贺君君李法财朱伟宁陈凯朱兴全
Owner LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com